Praxis Precision Medicines (PRAX) Tax Provisions (2020 - 2021)

Praxis Precision Medicines' (PRAX) quarterly Tax Provisions came in at -$5000.0 in Q4 2021, down 200.0% quarter-over-quarter from $5000.0 in Q3 2021.

Praxis Precision Medicines (PRAX) Tax Provisions (2020 - 2021) Analysis & Trends

Praxis Precision Medicines' Tax Provisions history runs 2 years deep, the most recent figure standing at -$5000.0 for Q4 2021.

On a quarterly basis, Tax Provisions changed N/A year-over-year to -$5000.0 in Q4 2021; TTM through Sep 2021 was $5000.0, a N/A change from a year earlier, with the FY2020 full-year figure at -$8000.0, up 90.48% from the prior year.
Tax Provisions fell to -$5000.0 in Q4 2021 per PRAX's latest filing, from $5000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $5000.0 in Q3 2021 and bottomed at -$11000.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	125,146.46
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-859,000.00
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	31.86 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-60.00 Mn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Praxis Precision Medicines	9.37 Bn	8.58 Bn	-	-

Download Data